Evolving Paradigms in Squamous NSCLC: Conclusion

Evolving Paradigms, Squamous NSCLC, Volume 1, Issue 1

Squamous cell lung cancer represents a distinct molecular pathologic NSCLC with unmet therapeutic needs, especially after failure of first-line platinum-based doublet chemotherapy.

This article is Part III of a series. View parts I and II:Evolving Paradigms in Squamous NSCLC> >